Fidelity Nasdaq Composite Index ETF
 
 
 
 
基本資料
種類: ETF
費用比率%: 0.21
資產淨值: 89.37
成立日期: 25/09/2003
 
分析
市值分佈:
96.62%
大市值
2.35%
中市值
0.31%
小市值
持股比例加總可能不達100%,原因包括ETF持有現金或衍生工具。
 
 
行業分佈 國家/地區分佈
 
投資組合
 (更新時間: 07/03/2026 05:53) 總持有投資項目: 987  
0%
 
100%
     10大 (58.19%)
代號 名稱 佔比% 持有日期
ELVNEnliven Therapeutics0.0127/02/2026
TBBKBancorp (The)0.0127/02/2026
VECOVeeco Instruments0.0127/02/2026
ESTAEstablishment Labs Holdings0.0127/02/2026
CLMTCalumet Inc.0.0127/02/2026
RAREUltragenyx Pharmaceutical0.0127/02/2026
CENTACentral Garden & Pet Company0.0127/02/2026
SKWDSkyward Specialty Insurance Group0.0127/02/2026
INVAInnoviva0.0127/02/2026
VEONVEON Ltd0.0127/02/2026
VERAVera Therapeutics0.0127/02/2026
SYBTStock Yards Bancorp0.0127/02/2026
IOSPInnospec0.0127/02/2026
CNTACentessa Pharmaceuticals plc0.0127/02/2026
TMCTMC the metals company0.0127/02/2026
ALGTAllegiant Travel Company0.0127/02/2026
DHCDiversified Healthcare Trust0.0127/02/2026
NWBINorthwest Bancshares0.0127/02/2026
PRGSProgress Software Corp0.0127/02/2026
DFTXDefinium Therapeutics Inc0.0127/02/2026
  1    2    3    4    5    6    7    8    9    10    11    12    13    14    15    16    17    18    19    20    21    22    23    24    25    26    27    28    29    30    31    32    33   34    35    36    37    38    39    40    41    42    43    44    45    46    47    48    49    50  
 

Copyright © 2026 ET Net Limited.
All rights reserved. Use of this site signifies your agreement to the terms of use.
DISCLAIMER: ET Net Limited and Third Party Information Providers endeavour to ensure the accuracy and reliability of the information provided, but do not guarantee its accuracy and reliability and accept no liability (whether in tort or contract or otherwise) for any loss or damage arising from any inaccuracies or omissions.